Table 2.

Positivity of different triage tests for histologically negative (No lesion), LSIL, HSIL, and CC

	No lesion (n = 60) % (95% CI)	LSIL (n = 107) % (95% CI)	(His)HSIL (n = 354) % (95% CI)	CC (n = 67) % (95% CI)
HPV16/18+	76.7 (67.7–79.8)	43.0 (39.8–45.7)	59.9 (54.1–64.2)	88.1 (83.2–95.4)
Cytology ≥(TCT)HSIL+	23.3 (19.8–26.4)	57.9 (54.2–60.1)	51.7 (45.9–56.8)	34.3 (28.0–36.1)
S5 at 2.85 cutoff	10.0 (7.6–13.8)	30.8 (27.9–35.0)	87.0 (84.3–89.7)	100
S5 at 3.7 cutoff	8.3 (3.2–13.9)	26.2 (20.2–31.8)	73.7 (69.8–77.6)	100
S5 at 0.8 cutoff	85.0 (77.9–89.4)	75.7 (69.9–78.8)	98.0 (92.4–99.7)	100

No lesion histologically negative without squamous intraepithelial lesion, LSIL low-grade squamous intraepithelial lesion, (His)HSIL high-grade squamous intraepithelial lesion, CC cervical cancer, (TCT)HSIL+ cytological high-grade squamous intraepithelial lesion or worse